In ₹ Crore except Per Share Latest Annual | ENTERO FY26 | MEDPLUS FY26 | EMIL FY26 | CRIZAC FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 69.97× | 35.94× | 69.12× | ◆ 14.38× | 35.94× +95% | |
| P/B | 4.59× | ◆ 4.01× | 4.55× | 5.32× | 4.55× +1% | |
| EV/EBITDA | 31.36× | 12.69× | 18.79× | ◆ 10.55× | 12.69× +147% | |
| Market Cap | ₹8,050 Cr | ₹7,909 Cr | ₹7,393 Cr | ₹3,150 Cr | ₹7,393 Cr +9% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | ◆ 14.78% | 9.67% | — | 12.22% | |
| Revenue CAGR 5Y | — | 17.56% | — | — | 17.56% | |
| Net Income CAGR 3Y | — | ◆ 63.65% | -4.45% | — | 29.60% | |
| Revenue YoY (latest Q) | 38.23% | 21.84% | ◆ 39.07% | -3.97% | 21.84% +75% | |
| Net Income YoY (latest Q) | 72.17% | -21.67% | ◆ 458.07% | 0.77% | 0.77% +9273% | |
| Profitability | ||||||
| EBITDA Margin | 4.03% | 8.81% | 6.10% | ◆ 27.41% | 8.81% -54% | |
| Net Income Margin | 2.21% | 3.19% | 1.49% | ◆ 21.03% | 3.19% -31% | |
| Return on Common Equity | 6.56% | 11.12% | 6.59% | ◆ 36.99% | 11.12% -41% | |
| Return on Capital Employed | 11.06% | 10.01% | 9.81% | ◆ 42.88% | 10.01% +10% | |
| Return on Assets | 4.05% | 5.58% | 2.82% | ◆ 25.03% | 5.58% -27% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.32× | ◆ 0.00× | 0.55× | 0.00× | 0.00× | |
| Interest Coverage | 4.09× | 2.69× | 1.84× | ◆ 3925.86× | 2.69× +52% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹6,591 Cr | ₹6,892 Cr | ₹7,183 Cr | ₹1,042 Cr | ₹6,892 Cr -4% | |
| Net Income | ₹146 Cr | ₹220 Cr | ₹107 Cr | ₹219 Cr | ₹219 Cr -33% | |
| Total Assets | ₹3,600 Cr | ₹3,933 Cr | ₹3,797 Cr | ₹876 Cr | ₹3,797 Cr -5% | |
| EPS | ₹26.44 | ₹18.33 | ₹2.78 | ₹12.52 | ₹12.52 +111% | |
| Book Value per Share | ₹402.78 | ₹164.48 | ₹42.26 | ₹33.86 | ₹42.26 +853% | |